Baidu
map

肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

2019 香港肾脏服务临床实践指南：普通肾脏病学

2019-03-24 香港医学相关专家组（统称） Nephrology (Carlton). 2019 Mar;24 Suppl 1:9-26.

普通肾脏病学

2019年3月，香港肾脏病学会(HKSN)发布了香港肾脏服务临床实践指南，本文未指南中关于普通肾脏病学部分内容，文章主要介绍了急性肾损伤和慢性肾脏病的定义和临床管理的相关内容。

中文标题：

2019 香港肾脏服务临床实践指南：普通肾脏病学

英文标题：

Clinical practice guidelines for the provision of renal service in Hong Kong: General Nephrology

发布机构：

香港医学相关专家组（统称）

发布日期：

2019-03-24

简要介绍：

2019年3月，香港肾脏病学会(HKSN)发布了香港肾脏服务临床实践指南，本文未指南中关于普通肾脏病学部分内容，文章主要介绍了急性肾损伤和慢性肾脏病的定义和临床管理的相关内容。 

拓展指南：与肾脏相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 香港肾脏服务临床实践指南：普通肾脏病学)] GetToolGuiderByIdResponse(projectId=1, id=8d1341c001e2a82d, title=2019 香港肾脏服务临床实践指南：普通肾脏病学, enTitle=Clinical practice guidelines for the provision of renal service in Hong Kong: General Nephrology, guiderFrom=Nephrology (Carlton). 2019 Mar;24 Suppl 1:9-26., authorId=null, author=, summary=2019年3月，香港肾脏病学会(HKSN)发布了香港肾脏服务临床实践指南，本文未指南中关于普通肾脏病学部分内容，文章主要介绍了急性肾损伤和慢性肾脏病的定义和临床管理的相关内容。 , cover=, journalId=null, articlesId=null, associationId=1311, associationName=香港医学相关专家组（统称）, associationIntro=, copyright=0, guiderPublishedTime=Sun Mar 24 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年3月，香港肾脏病学会(HKSN)发布了香港肾脏服务临床实践指南，本文未指南中关于普通肾脏病学部分内容，文章主要介绍了急性肾损伤和慢性肾脏病的定义和临床管理的相关内容。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>肾脏</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=d1afe1c001e2a452" title="2019 香港肾脏服务临床实践指南：血液透析" target=_blank>2019 香港肾脏服务临床实践指南：血液透析</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=6fb471c001e1381a" title="2019 接受肾脏保守治疗患者的护理建议-聚焦慢性肾病和症状的管理" target=_blank>2019 接受肾脏保守治疗患者的护理建议-聚焦慢性肾病和症状的管理</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=8880f1c0016e50b0" title="拟钙剂在慢性肾脏病患者中应用的专家共识" target=_blank>拟钙剂在慢性肾脏病患者中应用的专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=2e3231c0016a5ef2" title="2018 AISF/SIMI/SIMIT/SIN立场声明：慢性肾脏病患者丙型肝炎感染的管理" target=_blank>2018 AISF/SIMI/SIMIT/SIN立场声明：慢性肾脏病患者丙型肝炎感染的管理</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=8a6bf1c0016a48df" title="2018 KDIGO临床实践指南：慢性肾脏病患者丙型肝炎的预防，诊断，评估以及治疗" target=_blank>2018 KDIGO临床实践指南：慢性肾脏病患者丙型肝炎的预防，诊断，评估以及治疗</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E8%82%BE%E8%84%8F" target=_blank>有关肾脏更多指南</a></ul>, tagList=[TagDto(tagId=88838, tagName=普通肾脏病学)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5675, appHits=248, showAppHits=0, pcHits=3354, showPcHits=2846, likes=79, shares=4, comments=3, approvalStatus=1, publishedTime=Mon Apr 15 23:11:09 CST 2019, publishedTimeString=2019-03-24, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Apr 15 23:11:09 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:41:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 香港肾脏服务临床实践指南：普通肾脏病学)])
2019 香港肾脏服务临床实践指南：普通肾脏病学
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=896012, encodeId=8b26896012b8, content=求浏览, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ced55430036, createdName=ms5000000289546275, createdTime=Sun Nov 01 11:16:09 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881570, encodeId=52e18815e0e7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf635122606, createdName=1463b962m20(暂无昵称), createdTime=Tue Sep 01 00:44:04 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372247, encodeId=4bff3e22475d, content=诶，看不懂英文的悲哀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201128/af51e7ab063c4cb5a1eaafd80bad18aa/fcb292732e494cba9d2d5455e80aeaa7.jpg, createdBy=58a32217564, createdName=120ef166m69暂无昵称, createdTime=Wed Sep 04 08:55:02 CST 2019, time=2019-09-04, status=1, ipAttribution=)]
    2020-11-01 ms5000000289546275

    求浏览

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=896012, encodeId=8b26896012b8, content=求浏览, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ced55430036, createdName=ms5000000289546275, createdTime=Sun Nov 01 11:16:09 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881570, encodeId=52e18815e0e7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf635122606, createdName=1463b962m20(暂无昵称), createdTime=Tue Sep 01 00:44:04 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372247, encodeId=4bff3e22475d, content=诶，看不懂英文的悲哀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201128/af51e7ab063c4cb5a1eaafd80bad18aa/fcb292732e494cba9d2d5455e80aeaa7.jpg, createdBy=58a32217564, createdName=120ef166m69暂无昵称, createdTime=Wed Sep 04 08:55:02 CST 2019, time=2019-09-04, status=1, ipAttribution=)]
    2020-09-01 1463b962m20(暂无昵称)

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=896012, encodeId=8b26896012b8, content=求浏览, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ced55430036, createdName=ms5000000289546275, createdTime=Sun Nov 01 11:16:09 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881570, encodeId=52e18815e0e7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf635122606, createdName=1463b962m20(暂无昵称), createdTime=Tue Sep 01 00:44:04 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372247, encodeId=4bff3e22475d, content=诶，看不懂英文的悲哀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201128/af51e7ab063c4cb5a1eaafd80bad18aa/fcb292732e494cba9d2d5455e80aeaa7.jpg, createdBy=58a32217564, createdName=120ef166m69暂无昵称, createdTime=Wed Sep 04 08:55:02 CST 2019, time=2019-09-04, status=1, ipAttribution=)]
    2019-09-04 120ef166m69暂无昵称

    诶，看不懂英文的悲哀

    0

Baidu
map
Baidu
map
Baidu
map